Advance Care Planning Notifications in General Inpatient Medicine

October 15, 2024 updated by: Duke University
This study will evaluate the impact of and response by physicians on Hospital Medicine/General Internal Medicine service to a notification identifying seriously ill patients at high risk of death within 30 days as well as within 6 months in a cluster randomized control trial.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27705
        • Duke University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At least 18 years of age
  • Attending Physician on the Hospital Medicine or General Internal Medicine Service at Duke University Hospital

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Email and page notification sent to clinicians for patients at high-risk of mortality in 30 days and 6 months
No Intervention: Control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Proportion of advance care planning notes as measured by electronic health record data during hospitalization
Time Frame: Up to 30 days
Up to 30 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Proportion of advance care planning codes billed as measured by electronic health record data
Time Frame: Up to 30 days
Up to 30 days
Proportion of Palliative Care Consults (Inpatient/Outpatient) as measured by electronic health record data
Time Frame: Up to 90 days
Up to 90 days
Proportion of patients discharged to hospice as measured by electronic health record data
Time Frame: Up to 30 days
Up to 30 days
Proportion of patients' code status changed to Do-Not-Resuscitate as measured by electronic health record data
Time Frame: Up to 30 days
Up to 30 days
Proportion of patient deaths as measured by electronic health record data
Time Frame: Up to 14 days
Up to 14 days
Proportion of patient deaths as measured by electronic health record data
Time Frame: Up to 30 days
Up to 30 days
Proportion of patient deaths as measured by electronic health record data
Time Frame: Up to 6 months
Up to 6 months
Proportion of patient re-admitted to the hospital as measured by electronic health record data
Time Frame: Up to 30 days
Up to 30 days
Proportion of patient re-admitted to the hospital as measured by electronic health record data
Time Frame: Up to 6 months
Up to 6 months
Proportion of advance care planning paperwork filed as measured by electronic health record data
Time Frame: Up to 30 days
Up to 30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: David Casarett, MD, Duke University
  • Principal Investigator: Jessica Ma, MD, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2021

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

February 12, 2021

First Submitted That Met QC Criteria

February 12, 2021

First Posted (Actual)

February 16, 2021

Study Record Updates

Last Update Posted (Actual)

October 17, 2024

Last Update Submitted That Met QC Criteria

October 15, 2024

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00107026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advance Care Planning

Clinical Trials on Notification system

Subscribe